AbD Serotec

USA & Canada

3200 Atlantic Avenue, Suite 125
Raleigh, NC 27604, USA
Toll free: 1-800-265-7376
Fax: 919-878-3751
sales.us@ab-direct.com

http://www.ab-direct.com

UK & Ireland & Worldwide

Endeavour House, Langford Business Park
Langford Lane, Kidlington, Oxford, OX5 1GE, UK
Tel: +44 (0)1865 852 700
Fax: +44 (0)1865 852 739
sales.uk@ab-direct.com

http://www.ab-direct.com

 

Germany, Netherlands, Austria & Switzerland

Immermannstr. 13
40210 Dusseldorf, Germany
Tel: +49 (0)211 93 503 10/11
Fax: +49 (0)211 93 503 12
sales.de@ab-direct.com

 


 

AbD Serotec

AbD Serotec is the research and diagnostic antibody division of MorphoSys, one of the world’s leading antibody technology companies.

AbD Serotec Building

 

The AbD Serotec brand was created in early 2006 to market the combined products and services of Antibodies by Design, Biogenesis, Serotec, and Oxford Biotechnology – more than 10,000 antibodies and immunological reagents, custom monoclonal antibodies developed from the MorphoSys HuCAL library, and large and small scale antibody production and conjugation services.

 

AbD Serotec prides itself on its commitment to providing its customers in research and industry the highest quality products and services, and has a  ISO 9001:2000 and ISO 13485:2003 certified production facility in Kidlington, near Oxford UK. This facility is AbD Serotec’s headquarters, and supports sales offices in Raleigh, North Carolina and Duesseldorf, Germany. Custom monoclonal development services are performed at MorphoSys headquarters in Martinsried, near Munich in Germany.

 

MorphoSys

 

Morphosys Building

 

With its unique HuCAL technology (the Human Combinatorial Antibody Library) MorphoSys is developing the next generation of antibodies for treatment of disease and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.

 

Antibodies by Design

 

In early 2003, MorphoSys established Antibodies by Design to provide custom antibody development services to the research and diagnostic markets using its proven HuCAL technology. The speed of this service and the high specificity of the antibodies proved extremely popular in both academia and industry, resulting in the development of more than 4000 custom monoclonal antibodies.

 

Biogenesis

 

MorphoSys acquired the Biogenesis group of companies (Biogenesis Ltd in Poole, UK, and Biogenesis Inc in Brentwood, NH, USA) in January 2005 as a vehicle to bring HuCAL antibodies into the catalog antibody market. Biogenesis brought more than 20 years experience in the antibody industry and a large and diverse range of catalog antibodies to the MorphoSys group.

 

Serotec

 

In January 2006, MorphoSys added Serotec to its Research Antibody Division, and created the AbD Serotec brand. Since its establishment more than 20 years ago, Serotec has earned a strong position in the global market for research antibodies with direct sales operations in the UK, USA, Germany, France, and Scandinavia, distributors in more than 55 countries, and a large portfolio of antibodies and custom services.

 

Oxford Biotechnology (OBT)

 

Acquired with Serotec in January 2006, OBT was an internet-based antibody sales company, with customers all over the world. The OBT product portfolio is now also part of the AbD Serotec offering.